Reversal of gastric somatostatin receptor inhibition by Helicobacter pylori lipopolysaccharide with ebrotidine and sulglycotide

General Pharmacology

Volumn 28, Issue 5, 1997, Pages 705-708

  Piotrowski, J ^a   Skrodzka, D ^a   Slomiany, A ^a   Slomiany, B L ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

gastric mucosa; H. pylori lipopolysaccharide; somatostatin receptor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; EBROTIDINE; GASTRIN; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; SULGLICOTIDE;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; DOSE RESPONSE; DRUG ANTAGONISM; DUODENUM ULCER; HELICOBACTER PYLORI; HYPERGASTRINEMIA; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; STOMACH ACID SECRETION; STOMACH MUCOSA;

ANIMALS; ANTI-ULCER AGENTS; BENZENESULFONATES; CELL MEMBRANE; GASTRIC MUCOSA; HELICOBACTER PYLORI; LIPOPOLYSACCHARIDES; RATS; RECEPTORS, SOMATOSTATIN; SIALOGLYCOPROTEINS; SOMATOSTATIN; THIAZOLES;

EID: 0030999010     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00360-6     Document Type: Article

References (24)

1. 2-receptor antagonists. Eur. J. Med. Chem. 23, 97-100.
2. Barbara L., Biasco G., Capurso L., Dobrilla G., Lalli A., Paganelli G. M., Pallone F. and Torsoli A. (1990) Effects of sucralfate and sulglycotide, treatment on active gastritis and H. pylori colonization of the gastric mucosa in non-ulcer dyspepsia patients. Am. J. Gastroenterol. 85, 1109-1113.
3. Bianchi Porro G., Montrone F., Petrillo M., Caruso I. and Ardizzone S. (1993) Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. Scand. J. Gastroenterol. 28, 875-878.
4. El-Omar E. M., Penman I. D., Ardill J. E. S., Chittajallu R, S., Howie C. and McColl K. E. L. (1995) Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 109, 681-691.
5. El-Omar E., Penman I. D., Domian C. A., Ardill J. E. S. and McColl K. E. L. (1993) Eradicating Helicobacter pylori infection lowers gastrin-mediated acid secretion by two-thirds in patients with duodenal ulcer. Gastroenterology 34, 1060-1065.
6. Gabryelewicz A., Konturek S. J., Butruk G., Dzieniszewski J., Nowak A., Marlicz K., Marquez W., Torres J. and Ortiz J. A. (1994) Comparison of the efficacy and safety of ebrotidine and ranitidine in the treatment of duodenal ulcer. Gastroenterology 106, A79.
7. Galanos C., Luderitz O. and Westphal O. (1969) A new method for the extraction of R lipopolysaccharide. Eur. J. Biochem. 9, 245-249.
8. Goodwin C. S., Kirsch D. R., Chilvers T., Peters M., Collins D., Sly L., McConnell W. and Harper W. E. S. (1989) Transfer of C. pylory and C. mustelae to Helicobacter gen. nov. as H. pylori comb, nov and H. mustelae comb nov., respectively. Int. J. Syst. Bacteriol. 39, 397-405.
9. Graham D. Y., Lew G. M. and Leckago J. (1993) Antral G-cell and D-cell numbers in Helicobacter pylori infection: Effect of H. pylori eradication. Gastroenterology 104, 1655-1660.
10. Haruma K., Sumii K., Okamoto S., Yoshihara M., Sumii M., Kajiyama G. and Wanger S. (1995) Helicobacter pylori infection is associated with low antral somatostatin content in young adults. Scand. J. Gastroenterol. 30, 550-553.
11. He H. T., Johnson K., Thermos K. and Reisine T. (1989) Purification of a putative brain somatostatin receptor. Proc. Natl. Acad. Sci. USA. 86, 1480-4484.
12. McHenry L., Vuyyuru L. and Schubert M. L. (1993) Helicobacter pylori and duodenal ulcer disease: The somatostatin link. Gastroenterology 104, 1573-1575.
13. Moss S. F., Legon S., Bishop A., Polak J. M. and Calam J. (1992) Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 930-932.
14. Olbe L., Hamlet A., Dalenback J. and Fandriks L. (1996) A mechanism by which Helicobacter pylori infection of the antrum contributes to the development of duodenal ulcer. Gastroenterology 110, 1386-1394.
15. Piotrowski J., Majka J., Murty V. L. N., Czajkowski A., Slomiany A. and Slomiany B. L. (1994) Inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide: Effect of sulglycotide. Gen. Pharmac. 25, 959-976.
16. Piotrowski J., Majka J., Slomiany A. and Slomiany B. L. (1995a) Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal somatostatin receptor. Biochem. Mol. Biol. Int. 36, 491-498.
17. Piotrowski J., Piotrowski E., Slomiany A. and Slomiany B. L. (1995b) Susceptibility of Helicobacter pylori to antimicrobial agents: Effect of ebrotidine and ranitidine. J. Physiol. Pharmac. 46, 463-469.
18. Piotrowski J., Slomiany A., Murty V. L. N., Fekete Z. and Slomiany B. L. (1991) Inhibition of H. pylori colonization by sulfated gastric mucin. Biochem. Int. 24, 749-756.
19. Psilogenis M., Alberico P., Bianchi G. and Nazzari M. (1991) Sulglycotide. In Drugs in Gastroenterology (Edited by Braga P. D.), pp. 232-244. Raven Press, New York.
20. Slomiany B. L., Murty V. L. N., Piotrowski J. and Slomiany A. (1994) Gastroprotective agents in mucosal defense against Helicobacter pylori. Gen. Pharmac. 25, 833-841.
21. Slomiany B. L., Piotrowski J., Majka J. and Slomiany A. 1995a) Sucralfate affects the susceptibility of Helicobacter pylori to antimicrobial agents. Scand. J. Gastroenterol. 30(suppl. 210), 82-84.
22. Slomiany B. L., Piotrowski J., Majka J., Czajkowski A., Slomiany A. and Gabryelewicz A. (1995b) Enhancement in the protective qualities of gastric mucus by ebrotidine during duodenal ulcer healing. Gen. Pharmac. 26, 1039-1044.
23. Slomiany B. L., Piotrowski J., Murty V. L. N. and Slomiany A. (1992) Mechanism of ebrotidine protection against gastric mucosal injury induced by ethanol. Gen. Pharmac. 23, 719-727.
24. Tarnasky P. R., Kovacs T. O. G., Sytnik B. and Walsh J. H. (1993) Asymptomatic H. pylori infection impairs pH inhibition of gastrin and acid secretion during second hour peptone meal stimulation. Dig. Dis. Sci. 38, 1681-1687.